Answers are grounded in this paper and cite their sources.
VACS participants (regardless of HIV status) with elevated bilirubin levels had a lower risk of incident total CVD, acute myocardial infarction, heart failure, and ischemic stroke events after adjusting for known risk factors. Future studies should investigate how this apparently protective effect of elevated bilirubin could be harnessed to reduce CVD risk or improve risk estimation among HIV⁺ individuals.
No takes yet. Share an insight, caveat, or question.
Marconi et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: